BRIEF-Medicure Updates On Percutaneous Coronary Intervention Study
BRIEF-Medicure Updates On Percutaneous Coronary Intervention Study
简介-经皮冠状动脉介入治疗研究的最新药物
Nov 4 (Reuters) - Medicure Inc MPH.V :
路透11月4日电-Medicure Inc MPH.V:
* MEDICURE ANNOUNCES THAT THE SHORTENED AGGRASTAT® VERSUS INTEGRILIN® IN PERCUTANEOUS CORONARY INTERVENTION (SAVI-PCI) STUDY HAS MET ITS PRIMARY ENDPOINT
*Medure宣布,缩短的Aggrastat®与Integrlin®In Perkins冠状动脉介入(SAVI-PCI)研究已达到其主要终点
Source text for Eikon: ID:nCNW6qSwXa Further company coverage: MPH.V
Eikon的源文本:ID:nCNW6qSwXa进一步的公司报道:MPH.V
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com;)